loading

Aptevo Therapeutics Inc Azioni (APVO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Research and Development
5.81%
3.696
3.924 3.535 4.044 3.328
Operating Income/Loss
5.76%
-6.443
-6.837 -5.996 -7.61 -6.226
Income/Loss From Continuing Operations After Tax
5.09%
-6.356
-6.697 - -7.549 -6.204
Net Income/Loss
5.09%
-6.356
-6.697 -5.806 -7.549 -6.204
Basic Average Shares
12.79%
1.1964
1.0607 - 4.049 0.7381
Diluted Average Shares
12.79%
1.1964
1.0607 - 4.049 0.7381
Basic Earnings Per Share
17.16%
-5.31
-6.41 - -2.23 -8.40
Diluted Earnings Per Share
17.16%
-5.31
-6.41 - -2.23 -8.40
$6.58
price down icon 4.22%
$9.94
price down icon 3.21%
$5.53
price down icon 3.66%
$11.27
price down icon 6.16%
$18.60
price down icon 1.74%
WVE WVE
$3.13
price down icon 1.88%
Capitalizzazione:     |  Volume (24 ore):